PRIYA DESAI: Open Payments
NPI 1013568856 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 49 payments from 14 companies in 2025. Trend: 2023 $669 · 2024 $1,192 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $313 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| ABIOMED | 1 | $99 |
| Janssen Biotech, Inc. | 4 | $84 |
| Celltrion USA Inc. | 3 | $72 |
| Ardelyx, Inc. | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Novo Nordisk Inc | 2 | $49 |
| Braintree Laboratories, Inc. | 2 | $45 |
Products named: XIFAXAN, LINZESS, ENTYVIO, TREMFYA, CREON, VEGZELMA, RINVOQ, IBSRELA.
Industry payments across FL — which companies pay providers there.
